Prudential Financial Inc Karyopharm Therapeutics Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

A detailed history of Prudential Financial Inc transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 74,600 shares of KPTI stock, worth $47,744. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,600
Holding current value
$47,744
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.7 - $1.06 $52,220 - $79,076
74,600 New
74,600 $61,000
Q1 2024

May 14, 2024
SELL
$0.72 - $1.66 $3,744 - $8,632
-5,200 Reduced 20.96%
19,615 $29,000
Q4 2023

Feb 13, 2024
BUY
$0.68 - $1.31 $3,672 - $7,074
5,400 Added 27.81%
24,815 $21,000
Q3 2023

Nov 13, 2023
BUY
$1.14 - $1.81 $22,133 - $35,141
19,415 New
19,415 $26,000
Q4 2022

Feb 14, 2023
SELL
$2.48 - $5.93 $44,392 - $106,147
-17,900 Reduced 56.47%
13,800 $0
Q3 2022

Nov 04, 2022
SELL
$4.08 - $5.82 $80,784 - $115,236
-19,800 Reduced 38.45%
31,700 $173,000
Q2 2022

Aug 15, 2022
SELL
$4.15 - $8.37 $153,674 - $309,941
-37,030 Reduced 41.83%
51,500 $232,000
Q1 2019

May 15, 2019
BUY
$4.12 - $10.25 $61,800 - $153,750
15,000 Added 20.4%
88,530 $0
Q4 2018

Feb 07, 2019
BUY
$8.2 - $16.95 $422,381 - $873,094
51,510 Added 233.92%
73,530 $688,000
Q3 2018

Nov 07, 2018
SELL
$17.03 - $21.18 $8,174 - $10,166
-480 Reduced 2.13%
22,020 $0
Q2 2018

Aug 13, 2018
SELL
$12.0 - $19.88 $554,832 - $919,171
-46,236 Reduced 67.27%
22,500 $0
Q1 2018

May 04, 2018
BUY
$9.92 - $17.25 $492,091 - $855,703
49,606 Added 259.31%
68,736 $0
Q4 2017

Feb 13, 2018
BUY
$9.15 - $11.99 $175,039 - $229,368
19,130
19,130 $184,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email